《肾眼同治-代谢记忆与糖尿病微血管病变（英文版）》经典培训课件.pptxVIP

;2000;DCCT/EDIC - Long-term Microvascular Risk Reductionin Type 1 Diabetes;In individuals with type 1?diabetes, intensive?diabetes?treatment yields durable renal benefits that persist for at least 18 years after its application. DCCT INT and the attendant 6.5 years of lower HbA1c had long-term salutary effects on the development and progression of atherosclerosis and cardiovascular disease during the subsequent follow-up during EDIC. The persistent effects of prior intensive therapy on neuropathy measures through 14 years of EDIC largely mirror those observed for other?diabetes?complications.